Vanda Pharmaceuticals Inc. (VNDA)

NASDAQ: VNDA · Real-Time Price · USD

3.980

-0.050 (-1.24%)

At close: May 13, 2025, 4:00 PM

3.951

-0.029 (-0.73%)

Pre-market: May 14, 2025, 8:31 AM EDT

Vanda Pharmaceuticals Market Cap

Vanda Pharmaceuticals has a market cap or net worth of $234.56 million as of May 14, 2025. Its market cap has decreased by -9.02% in one year.

Market Cap

234.56M

Enterprise Value

-94.60M

1-Year Change

-9.02%

Ranking

#3513

Market Cap Chart

Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $234.56M, an increase of 11.96%. That is a compound annual growth rate of 0.59%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	237.50M	-14.97%
Dec 31, 2024	279.30M	15.03%
Dec 29, 2023	242.80M	-41.94%
Dec 30, 2022	418.20M	-52.16%
Dec 31, 2021	874.10M	21.64%
Dec 31, 2020	718.60M	-17.90%
Dec 31, 2019	875.30M	-36.13%
Dec 31, 2018	1.37B	100.69%
Dec 29, 2017	682.90M	-2.57%
Dec 30, 2016	700.90M	75.84%
Dec 31, 2015	398.60M	-17.90%
Dec 31, 2014	485.50M	17.87%
Dec 31, 2013	411.90M	294.54%
Dec 31, 2012	104.40M	-21.97%
Dec 30, 2011	133.80M	-49.57%
Dec 31, 2010	265.30M	-13.30%
Dec 31, 2009	306.00M	2,200.75%
Dec 31, 2008	13.30M	-92.75%
Dec 31, 2007	183.40M	-66.04%
Dec 29, 2006	540.00M	157.76%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	669.76B
Johnson & Johnson	357.16B
AbbVie	332.08B
Novo Nordisk	291.59B
UnitedHealth Group	282.47B
Abbott Laboratories	224.53B
Novartis AG	209.81B
AstraZeneca	209.59B

Market Cap Rankings